Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1127 results for "us fda"

FDA Approves New Cancer Medication
Daily Rx

FDA approves Gilead Sciences drug for 3 cancers

WASHINGTON The Food and Drug Administration on Wednesday approved a new cancer drug from Gilead Sciences Inc. to treat three types of blood cancer. Regulators approved the drug for patients with forms of chronic lymphocytic leukemia, follicular ..., 10 hours ago
FDA Approves New Cancer Medication Daily Rx, 5 minutes ago

1,308 images for us fda

Money Today, 2 days ago
NDTV Profit, 1 day ago
MassDevice, 2 days ago
Pharma Letter, 1 day ago
Pharma Letter, 1 day ago
Orlando Sentinel, 9 hours ago
Reuters, 6 hours ago
MassDevice, 3 weeks ago
Yahoo! News, 11 hours ago
Orlando Sentinel, 5 days ago

22ND CENTURY : Engages CRO for FDA Regulatory Activities of Company's Modified Risk Cigarettes

By a News Reporter-Staff News Editor at Pharma Business Week -- 22nd Century Group, Inc. (NYSE MKT: XXII) announced that it has engaged a major a contract research organization ("CRO") with extensive experience in tobacco exposure studies to assist ...
 4 Traders1 hour ago US FDA accepts Avanir Pharma's IND application for phase II study of AVP-786 for adjunctive treatment of MDD  PharmaBiz1 day ago FDA fast-tracks Roche's Avastin for tough-to-treat ovarian cancer  FierceMedicalDevices21 hours ago FDA Grants Genentech's Avastin Priority Review In Ovarian Cancer  RTTNews.com1 day ago

Ipca Lab dips on FDA observations on Ratlam plant

Ipca Laboratories has dipped 6% to Rs 788 on National Stock Exchange (NSE) after drug maker said it has received certain inspection observations from the US Food and Drug Administration (FDA) over manufacturing at its Ratlam plant in Madhya Pradesh.
 Business Standard India8 minutes ago

Ipca voluntarily stops medicine exports to US on FDA directive

Ipca Labs has voluntarily stopped medicine exports from its Ratlam (Madhya Pradesh) plant to the United States market, following a 483 regulatory observation by the US Food and Drug Administration. The company shares plunged close to 5 per cent on ...
 Hindu Business Line11 minutes ago
Med India

FDA approves Zydelig for three types of blood cancers

The U.S. regulator grants traditional approval for Gilead Sciences' ( GILD +0.4% ) Zydelig ( idelalisib ) as a treatment for chronic lymphocytic leukemia (CLL) that has relapsed. Zydelig is to used with Rituxan ( rituximab ) ( OTCQX:RHHBY +0.3% ) ...
 Seeking Alpha11 hours ago FDA Approves Indications for Zydelig for Three Blood Cancers—CLL, FL, and SLL  Oncology Times3 hours ago FDA approves Zydelig (idelalisib) to treat blood cancers - news release  Food Consumer10 hours ago Statement from FDA Confirms Approval of Gilead's Zydelig  Benzinga.com12 hours ago
Bioresearch Online

Dispute Over FDA Bid To Destroy Personally Imported Drugs

07/17/14, in-Pharma Technologist body: Pharma groups and patients have objected to U.S. Food and Drug Administration (FDA) plans to destroy prescription medicines personally imported into the U.S.
 AAPS Pharmceutica3 hours ago Sucampo says FDA approves addition of Nitto Medic as Rescula production site  Yahoo! Finance1 day ago Octapharma receives FDA approval for immune thrombocytopenic purpura drug  Individual.com1 day ago Salix and Pharming receive FDA approval for hereditary angioedema drug  Individual.com1 day ago

FDA warns that recalled drugs from Texas specialty pharmacy may be contaminated

WASHINGTON The Food and Drug Administration is warning doctors not to use compounded drugs from a Texas specialty pharmacy due to risks of contamination. The agency says FDA inspectors recently uncovered unsanitary conditions at Unique ...
 FOXBusiness.com8 hours ago FDA Warns of Compounded Drug Recall by Texas Firm  ABC News8 hours ago

FDA Confirms Endpoints of Androxal Study; Paladin Labs Announces the Canadian Launch of Veregen®

[July 23, 2014] (BioMed Reports Via Acquire Media NewsEdge) Below is a look at some of the headlines for companies that made news in the healthcare sector on July 16, 2014. {nfg}Repros Therapeutics Inc.® (Nasdaq: RPRX) today ...
 TMC Net3 hours ago
Daily Rx

FDA OKs Injectable Dantrolene for Malignant Hyperthermia

The US Food and Drug Administration (FDA) has approved an injectable form of dantrolene sodium ( Ryanodex , Eagle Pharmaceuticals) for rapid treatment of malignant hyperthermia (MH), along with the appropriate supportive measures, the company ...
 American Journal of Public Health3 hours ago FDA Approves Eagle Pharmaceuticals Ryanodex® for the Treatment of Malignant Hyperthermia  Enhanced Online News17 hours ago FDA Approves Eagle Pharmaceuticals' Ryanodex® for the Treatment of Malignant Hyperthermia  TMC Net16 hours ago 7/23/14 - FDA Approves Eagle Pharmaceuticals' Ryanodex For The Treatment Of Malignant Hyperthermia  Pharmacy Choice9 hours ago

FDA approves abuse-deterrent painkiller

The Food and Drug Administration on Wednesday announced the approval of Targiniq ER, an extended-release painkiller designed to combat abuse and counter a national scourge of prescription drug abuse. Targiniq ER contains a component that blocks ...
 The Hill5 hours ago FDA approves ER oxycodone formulation designed to deter abuse  Orthopedics Today2 hours ago FDA approves new extended-release oxycodone with abuse-deterrent properties  U.S. Food and Drug Administration5 hours ago FDA approves Targiniq ER with abuse-deterrent properties  FirstWord Pharma6 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - us fda
Get updated on latest news & your favorite topics right in your inbox!
More     Less